Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
Condition: Female Breast Cancer Interventions: Drug: Hormonal Antineoplastics; Drug: Chemotherapy drug Sponsor: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
Condition: Breast Cancer Interventions: Drug: Standard of care administration of Endocrine therapy; Drug: Dose-frequency escalation administration of Endocrine therapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials
Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
Conditions: Breast Neoplasm Female; Arthralgia; Aging Intervention: Drug: Aromatase inhibitor Sponsor: University of Michigan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Conditions: Invasive Mammary Carcinoma; Metastatic Breast Cancer Interventions: Drug: Capecitabine; Other: Endocrine-therapy; Other: MammoPrint ® and BluePrint assays Sponsors: Sonya Reid; Agendia; Susan G. Komen Breast Cancer Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2023 Category: Research Source Type: clinical trials
